ClearNote Health to Present Pancreatic Cancer Test Data at DDW 2026
ClearNote Health will present data at DDW 2026 showing its Avantect Pancreatic Cancer Test achieved 82.6% sensitivity and 97.5% specificity in patients at elevated risk.
Category: Cancer
Cancer
Latest
Cancer
Latest
NeoGenomics Integrates Cancer Testing with Epic Electronic Health Records
NeoGenomics has integrated its oncology testing portfolio with Epic Aura, allowing physicians nationwide to order tests and view results within the Epic EHR system, aiming to streamline workflows and expand test adoption, according to the company.
Cancer
Latest
Labcorp Launches Companion Diagnostic for Ovarian Cancer Treatment
Labcorp has launched nationwide testing with Agilent’s FDA-approved PD-L1 IHC 22C3 pharmDx, enabling identification of patients with platinum-resistant ovarian cancer eligible for pembrolizumab immunotherapy.
ViewsML to Present Virtual Staining Research at AACR 2026
ViewsML will present research on its AI-powered virtual immunohistochemistry platform at AACR 2026, highlighting biomarker detection from routine H&E slides without traditional staining.
Read More
GeneCentric Data Suggest Fragmentomics Could Expand Liquid Biopsy Beyond Mutation Testing
Presentations at AACR 2026 will showcase fragmentomics-based technology for detecting therapeutic markers and providing prognostic insight.
Read More
NeoGenomics to Spotlight AI-Driven Genomic–Clinical Data Integration at AACR 2026
Presentations at the upcoming annual meeting will focus on AI-based analysis, biomarker prevalence, and therapy development.
Read More
Labcorp and Children’s Hospital of Philadelphia Partner to Expand Pediatric Diagnostic Access
The collaboration aims to create an innovation pipeline for specialized pediatric tests across oncology, metabolic disease, and autoimmune conditions.
Read More
Ataraxis AI Launches Test to Predict Response to Neoadjuvant Therapy in Breast Cancer
The tool uses digitized pathology slides to estimate how patients will respond to therapy before surgery.
Read More
Blood-Based Biomarker Identifies Cancer Risk in Lynch Syndrome Patients
Researchers at MD Anderson have identified a blood-based biomarker using T cell receptor sequencing that may help assess cancer risk in asymptomatic Lynch syndrome carriers, according to a study in Nature Communications.
Read More
FDA Clears At-Home Cervical Cancer Screening Tool
The clearance of the Onclarity HPV Self-Collection Kit and approval of the BD Onclarity HPV Assay aim to reduce barriers for unscreened populations.
Read More
Multi-Cancer Early Detection Test Added to Evexia Diagnostics Platform
20/20 BioLabs’ AI-powered multi-cancer early detection test, OneTest for Cancer, is now available to approximately 40,000 clinicians via the Evexia Diagnostics platform.
Read More
New Research on Automated Myeloid Testing and Molecular Residual Disease to be Presented at AACR 2026
Biodesix will present seven abstracts—including two oral sessions—at AACR 2026, highlighting advances in automated myeloid testing, liquid biopsy, and NGS-based cancer monitoring platforms.
Read More
DecisionDx-Melanoma Gene Expression Test Improves Risk Prediction Beyond Standard Staging
Data from nearly 1,900 SEER-linked patients show the test identifies meaningful survival differences within the same AJCC stage.
Read More
EpiCapture Urine-Based Prostate Cancer Test Shows High Accuracy in Clinical Study
The updated urine test utilizes machine learning and patient ethnicity to provide individualized risk scores for aggressive disease.
Read More
Home HPV Self-Sampling Kits Show Promise for Closing Cervical Screening Gap in Disabled Women
A new survey-based study finds that more than half of physically Disabled women would prefer at-home human papillomavirus testing over traditional clinic-based cervical screening.
Read More
Urine-Based Liquid Biopsy Shows High Sensitivity for Prostate Cancer Detection
A new study validates a machine-learning platform that detects prostate cancer through biochemical patterns in urine samples.
Read More
New Whole Genome and Transcriptome Assay Launches for Myeloid Malignancies
Caris Life Sciences has launched Caris ChromoSeq, a whole genome and transcriptome sequencing assay for myeloid malignancies, designed to consolidate multiple tests into a single workflow with a seven-day turnaround.
Read More
Blood Test Using Inflammatory Biomarkers Advances for Colorectal Cancer Detection
Irish researchers have secured €670,000 to clinically validate a blood-based colorectal cancer screening test using inflammatory biomarkers, aiming for launch by 2027 through a new spin-out company.
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- 186
- 187
- 188
- 189
- 190
- 191
- 192
- 193
- 194
- ...
- 195